Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"
PPJ
1 other identifier
interventional
81
1 country
1
Brief Summary
The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed "Positive Recovery Journaling" (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedResults Posted
Study results publicly available
June 20, 2024
CompletedJune 20, 2024
May 1, 2024
1.3 years
May 21, 2020
December 21, 2022
May 29, 2024
Conditions
Outcome Measures
Primary Outcomes (12)
Satisfaction With Life at Baseline
Score on the "Satisfaction with Life" scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
Baseline
Satisfaction With Life at 2 Weeks
Score on the "Satisfaction with Life" scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
2 weeks (after Phase 1, the group phase)
Satisfaction With Life at 4 Weeks
Score on the "Satisfaction with Life" scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
4 weeks (after Phase 2, the independent practice phase)
Satisfaction With Life at 8 Weeks
Score on the "Satisfaction with Life" scale. This scale has 5 items assessed on a 7 point Likert-type response format. Scores range from 5 to 35 with higher scores representing higher satisfaction with life.
8 weeks (the 1-month post-intervention)
Happiness With Recovery at Baseline
Score on a single item, "In general, I am happy with my recovery." This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
Baseline
Happiness With Recovery at 2 Weeks
Score on a single item, "In general, I am happy with my recovery." This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
2 weeks (after Phase 1, the group phase)
Happiness With Recovery at 4 Weeks
Score on a single item, "In general, I am happy with my recovery." This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
4 weeks (after Phase 2, the independent practice phase)
Happiness With Recovery at 8 Weeks
Score on a single item, "In general, I am happy with my recovery." This item uses an 11 point scale ranging from 0 to 10. Higher scores represent higher happiness with recovery.
8 weeks (the 1-month post intervention)
Commitment to Sobriety at Baseline
Score on a single item, "I am willing to do whatever it takes to recover from my addiction." This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
Baseline
Commitment to Sobriety at 2 Weeks
Score on a single item, "I am willing to do whatever it takes to recover from my addiction." This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
2 weeks (after Phase 1, the group phase)
Commitment to Sobriety at 4 Weeks
Score on a single item, "I am willing to do whatever it takes to recover from my addiction." This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
4 weeks (after Phase 2, the independent practice phase)
Commitment to Sobriety at 8 Weeks
Score on a single item, "I am willing to do whatever it takes to recover from my addiction." This item uses an 11 point scale ranging from 0-10. Higher scores represent greater commitment to sobriety.
8 weeks (the 1-month post intervention)
Study Arms (2)
Treatment Group
EXPERIMENTALParticipants in this group will complete the intervention, Positive Peer Journaling (PPJ), while also continuing to attend intensive outpatient treatment for addiction.
Control Group
NO INTERVENTIONThere will be no intervention for those randomized to the control group. However, they will complete assessment instruments throughout the study period while also continuing to attend intensive outpatient treatment for addiction.
Interventions
PPJ is a journaling practice to support addiction recovery. PPJ encourages past 24 hour review and upcoming 24 hour planning to improve subjective wellbeing in recovery and reduce relapse. PPJ uses journals with column headings under which individuals make bullet-pointed lists. On the left hand page, past 24 hours is recalled, itemizing "good" and "bad" things that happened and things for which one is grateful. Good wishes for others are also expressed on this page. On the right hand page, values-based activities for the upcoming 24 hours are planned via headings representing valued life domains such as "recovery," "work/school," "spirituality," "home and household," and "health."
Eligibility Criteria
You may qualify if:
- meet DSM-V criteria for past-year Substance Use Disorder as primary or secondary diagnosis,
- English literacy sufficient to make short written lists needed to complete PPJ and homework assessments,
- minimum 2 weeks sustained abstinence,
- completed first 2 weeks of treatment at Nuway (approximately 2 weeks), an intensive outpatient substance use disorder treatment program and the recruitment site,
- agree to be audio recorded or transcription recorded in group meetings and in individual meetings with research staff,
- currently are clients in the Nuway outpatient program,
- participants must be English speaking and literacy must be strong enough to write short lists and to understand the questions asked in the questionnaires,
- participants must have an electronic device that connects to the internet and internet connection for online delivery of intervention during COVID-19.
You may not qualify if:
- presence of a psychotic disorder, psychiatric condition (e.g., suicidal ideation), or cognitive impairment (e.g., severe dementia, traumatic brain injury) limiting ability to give consent and/or participate in the study;
- severe psychiatric illness (current schizophrenia, major depression with suicidal ideation);
- personality disorders that would interfere with satisfactory participation in or completion of the study protocol,
- inability to give informed, voluntary consent to participate,
- lack of sufficient English literacy to participate, defined as inability to make a list of 5 things they did yesterday and inability to understand questionnaire items,
- any impairment, activity, or situation that in the judgement of the research staff would prevent satisfactory participation in or completion of the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NUWAY
Minneapolis, Minnesota, 55413, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Amy R. Krentzman
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Krentzman, MSW, PhD
University of Minenesota
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2020
First Posted
July 7, 2020
Study Start
July 7, 2020
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
June 20, 2024
Results First Posted
June 20, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share